Radialis

company

About

The Radials PET Imager is a groundbreaking versatile nuclear imaging system delivering high-resolution images with low radiotracer doses.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$500K
Industries
Health Care,Medical Device
Founded date
Feb 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Developer of an organ-targeted positron emission tomography (PET) imaging system designed for high-definition and low-dose applications in oncology, neurology, and cardiology. The company's technology has ten times the efficiency for detecting radiotracer compared to traditional PET systems. The system has broad FDA clearance in the U.S. for imaging and measuring injected positron emitting radiopharmaceuticals. The current leading (reimburseable) indication is high resolution imaging of primary solid tumors for treatment planning, particularly as an adjunct to traditional staging PET/CT without additional radiotracer. The company is also pursuing targeted early detection of cancer and Alzheimer's disease with low-dose imaging in high-risk populations.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$0.93M $550K
Radialis has raised a total of $0.93M $550K in funding over 2 rounds. Their latest funding was raised on Apr 13, 2021 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 13, 2021 Debt Financing $500K 1 FedNor Detail
Aug 11, 2020 Grant $434K 1 Northern Ontario Heritage Fund Detail
Mar 31, 2019 Funding Round $550K 1 Tenacity Capital Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Radialis is funded by 3 investors. FedNor and Northern Ontario Heritage Fund are the most recent investors.
Investor Name Lead Investor Funding Round
FedNor Yes Debt Financing
Northern Ontario Heritage Fund Yes Grant
Tenacity Capital Yes Funding Round